Characterization of the ovarian and reproductive abnormalities in prepubertal and adult estrogen non-responsive estrogen receptor alpha knock-in (ENERKI) mice. 2009

K W Sinkevicius, and K Woloszyn, and M Laine, and K S Jackson, and G L Greene, and T K Woodruff, and J E Burdette
The Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.

Estrogen non-responsive estrogen receptor alpha (ERalpha) knock-in (ENERKI) mice have a mutation (glycine 525 to leucine, G525L) in the ligand-binding domain of ERalpha. The mutant ERalpha protein has a significantly lower affinity and response to endogenous estrogens, while not altering growth factor activated ligand-independent pathways. ENERKI females demonstrated signs of early follicle development as determined by a significant increase in antral follicle formation by 20 days of age. Adult ENERKI females were infertile, had hemorrhagic ovarian follicular cysts, and failed to develop corpora lutea in response to a superovulation regimen. These results illustrate the importance of ERalpha ligand-induced signaling for ovarian development and for estrogen feedback on the hypothalamus and pituitary. Although ERalpha ligand-induced signaling by endogenous estrogens is lost in ENERKI females, the ERalpha selective agonist propyl pyrazole triol (PPT), a synthetic nonsteroidal compound, is still able to activate G525L ERalphain vivo to increase uterine weight. To test whether PPT could restore ligand-dependent receptor activation, ENERKI females were treated with PPT and evaluated for spontaneous ovulation, ovarian hemorrhagic cysts, and LH serum levels. Daily PPT treatments beginning on day 4 of life prevented formation of ovarian hemorrhagic cysts in adult ENERKI animals. In accordance with this result, preputial gland weight and LH levels were also lowered in these animals, indicating PPT treatments most likely led to restoration of ERalpha negative feedback of the hypothalamic-pituitary axis.

UI MeSH Term Description Entries
D007246 Infertility A reduced or absent capacity to reproduce. Sterility,Reproductive Sterility,Sterility, Reproductive,Sub-Fertility,Subfertility
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008297 Male Males
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females

Related Publications

K W Sinkevicius, and K Woloszyn, and M Laine, and K S Jackson, and G L Greene, and T K Woodruff, and J E Burdette
June 1998, Endocrinology,
K W Sinkevicius, and K Woloszyn, and M Laine, and K S Jackson, and G L Greene, and T K Woodruff, and J E Burdette
June 1999, Endocrinology,
K W Sinkevicius, and K Woloszyn, and M Laine, and K S Jackson, and G L Greene, and T K Woodruff, and J E Burdette
December 2017, Genesis (New York, N.Y. : 2000),
K W Sinkevicius, and K Woloszyn, and M Laine, and K S Jackson, and G L Greene, and T K Woodruff, and J E Burdette
August 2008, Molecular and cellular endocrinology,
K W Sinkevicius, and K Woloszyn, and M Laine, and K S Jackson, and G L Greene, and T K Woodruff, and J E Burdette
May 2001, Biology of reproduction,
K W Sinkevicius, and K Woloszyn, and M Laine, and K S Jackson, and G L Greene, and T K Woodruff, and J E Burdette
January 2000, In vitro cellular & developmental biology. Animal,
K W Sinkevicius, and K Woloszyn, and M Laine, and K S Jackson, and G L Greene, and T K Woodruff, and J E Burdette
April 1999, Neuroscience letters,
K W Sinkevicius, and K Woloszyn, and M Laine, and K S Jackson, and G L Greene, and T K Woodruff, and J E Burdette
January 2000, Journal of the Society for Gynecologic Investigation,
K W Sinkevicius, and K Woloszyn, and M Laine, and K S Jackson, and G L Greene, and T K Woodruff, and J E Burdette
November 2000, The Journal of steroid biochemistry and molecular biology,
K W Sinkevicius, and K Woloszyn, and M Laine, and K S Jackson, and G L Greene, and T K Woodruff, and J E Burdette
May 2007, Reproduction (Cambridge, England),
Copied contents to your clipboard!